If you run a revenue cycle management, healthcare IT, or credentialing company, you probably think of your business as “healthcare services.” You might assume you’re in the same financing category as physician practices or outpatient centers.
You’re not. And that difference matters more than most B2B healthcare entrepreneurs realize.
Lenders Don’t View All Healthcare the Same Way
Here’s what catches many healthcare business owners off guard: Lenders explicitly categorize healthcare businesses into distinct tiers based on a single critical factor—reimbursement risk exposure.
Tier 1 (Most Favorable): Healthcare business services companies
RCM, healthcare IT, credentialing services, consulting. B2B revenue models not exposed to payor reimbursement changes.
Tier 2 (Favorable): Outpatient practices with diversified payor mix
Physical therapy, behavioral health, ASCs. Subject to reimbursement changes but with manageable commercial payor percentages.
Tier 3 (Complex): Heavy Medicaid concentration, hospitals, SNFs
High reimbursement risk, regulatory complexity, margin pressure from payor mix.
If you’re running an RCM company or healthcare IT business, you’re in Tier 1—the category lenders prefer.
Why Reimbursement Risk Matters So Much
When CMS announces a 2% cut to the Medicare Physician Fee Schedule, physician practices see immediate margin compression. Their revenue drops because they bill patients and payors directly.
RCM companies? Their margins don’t budge.
That’s because RCM, healthcare IT, and credentialing companies bill providers, not patients or payors. Your revenue comes from B2B contracts with healthcare organizations. When reimbursement rates change, your clients feel the impact—but your cash flows remain predictable.
This single distinction drives everything lenders care about:
- Predictable cash flows: B2B contracts with annual renewals, not fee-for-service volatility
- Insulation from policy changes: CMS rate adjustments, payor contract renegotiations, Medicaid expansion—none directly affect your revenue
- Client diversification: Easier to build a base of 50-100 provider clients than to diversify 10,000 individual patients across payor types
- Recurring revenue: Most B2B healthcare services operate on subscription or percentage-of-collections models with high retention (95%+ is common in RCM)
Lenders view these characteristics as lower risk. And lower risk translates directly to better financing terms.
The Real Differences in Debt Terms
Here’s what Tier 1 positioning means in practical terms:
Leverage multiples:
- Healthcare B2B services: 3-5x EBITDA
- Physician practices: 2-3x EBITDA
Valuation benchmarks:
- RCM and healthcare IT platforms: 12-30x EBITDA for established companies
- Physician practices: 6-12x EBITDA
Lending structures available:
- B2B healthcare services with software components can access ARR-based lending—financing structures typically reserved for SaaS companies
- Traditional healthcare providers generally limited to cash flow-based lending
Covenant flexibility:
- Lenders more comfortable with growth-oriented covenants for B2B models
- Practice-based models face tighter restrictions due to reimbursement uncertainty
Consider two $22 million revenue healthcare companies—one is an RCM business, one is a physical therapy practice. The RCM company can typically access $10-15 million in debt financing at favorable rates. The practice might access $6-8 million with more restrictive terms, despite identical revenue.
The difference? Reimbursement risk.
What This Means If You’re in the B2B Category
If your healthcare business is RCM, healthcare IT, credentialing, or another B2B service model, you have financing advantages many entrepreneurs don’t recognize:
- More lender options. Lenders who won’t touch physician practices will actively pursue B2B healthcare services deals.
- Better leverage for acquisitions. The $248 billion invested in the RCM sector through 2,300+ deals wasn’t just PE money—debt financing fueled much of that consolidation. If you’re considering acquiring a competitor, your B2B model makes that financing more accessible.
- Qualification for software-like financing structures. If your business has meaningful software/SaaS revenue (40-60%+ of total revenue), you may qualify for ARR-based lending with even better terms than traditional cash flow lending.
- Positioning strength in debt markets. When you approach lenders, you’re not asking them to take healthcare reimbursement risk. You’re offering them a B2B services cash flow story that happens to be in healthcare—a much easier underwriting conversation.
How to Leverage This Advantage
Understanding your Tier 1 positioning changes how you approach capital raising:
When speaking with lenders, emphasize your B2B model upfront. Don’t bury it in due diligence—lead with “We’re a healthcare business services company with B2B revenue, not exposed to reimbursement risk.”
When evaluating growth opportunities, recognize that your business model makes debt financing for acquisitions or expansion more accessible than you might assume. You’re not competing with physician practices for lender attention—you’re in a preferred category.
When considering PE offers, understand that debt financing is a viable alternative precisely because of your B2B model. The same characteristics that make PE firms willing to pay 12-30x EBITDA for RCM platforms also make debt lenders willing to finance your growth at attractive terms.
The Bigger Question
We recently explored why RCM company owners are choosing debt over private equity. Now we’ve established why B2B healthcare services companies are especially well-positioned to access that debt.
But here’s where it gets interesting: The same market fragmentation that makes the RCM sector attractive to PE firms also creates opportunity for entrepreneur-led consolidation.
If you’re in Tier 1—with better leverage multiples, more lender options, and favorable financing terms—the question isn’t just “Should I take PE’s offer?”
The question becomes: Should you be the one doing the acquiring?
The $19B RCM market remains highly fragmented. While 113 PE-backed platforms are executing buy-and-build strategies, thousands of independent companies are still owned by entrepreneurs approaching retirement.
Small RCM companies trade at 3-6x EBITDA. Large platforms command 12-30x EBITDA.
That arbitrage opportunity isn’t reserved for PE firms. With debt financing, RCM entrepreneurs can execute the same rollup playbook—maintaining 100% ownership while building enterprise value.
We’ll explore that strategy in our next article.
Ready to explore your financing options? CAPX helps healthcare business services companies access debt financing from multiple lenders efficiently. Contact us to discuss your growth capital strategy.
